Vincenzo De Pangher Manzini

Summary

Country: Italy

Publications

  1. ncbi Malignant peritoneal mesothelioma
    Vincenzo De Pangher Manzini
    Azienda per i Servizi Sanitari 2 Isontina, Ospedali di Monfalcone e Gorizia, Unità Operativa Complessa di Oncologia, Monfalcone, GO, Italy
    Tumori 91:1-5. 2005
  2. ncbi Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1)
    Carmine Pinto
    Unit of Medical Oncology, S Orsola Malpighi Hospital, Via Albertoni 15, 40138 Bologna, Italy
    Lung Cancer 52:199-206. 2006

Collaborators

Detail Information

Publications2

  1. ncbi Malignant peritoneal mesothelioma
    Vincenzo De Pangher Manzini
    Azienda per i Servizi Sanitari 2 Isontina, Ospedali di Monfalcone e Gorizia, Unità Operativa Complessa di Oncologia, Monfalcone, GO, Italy
    Tumori 91:1-5. 2005
    ..The clinical characteristics of malignant peritoneal mesothelioma are not fully known, and it appears as a variable entity with different types of clinical presentation and with a difficult diagnosis...
  2. ncbi Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1)
    Carmine Pinto
    Unit of Medical Oncology, S Orsola Malpighi Hospital, Via Albertoni 15, 40138 Bologna, Italy
    Lung Cancer 52:199-206. 2006
    ....